• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本福岛县 22 年间过敏性紫癜肾炎的发病及严重程度。

The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan.

机构信息

Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima City, Fukushima, 960-1295, Japan.

出版信息

Int Urol Nephrol. 2010 Dec;42(4):1023-9. doi: 10.1007/s11255-009-9701-3. Epub 2010 Jan 10.

DOI:10.1007/s11255-009-9701-3
PMID:20063060
Abstract

BACKGROUND

Recently, there have been a few reports on the decrease in the incidence of severe Henoch-Schönlein purpura nephritis (HSPN) in Japan. To evaluate the incidence and the severity of HSPN, we examined the epidemiology and clinical manifestations of HSPN in Fukushima Prefecture over a 22-year period.

METHODS

We enrolled 61 patients (Group 1) diagnosed with HSPN between 1987 and 1997 and a further 59 patients (Group 2) diagnosed with HSPN between 1998 and 2008. Epidemiology, clinical features, laboratory data, pathological findings, treatment and outcome were retrospectively compared between the two groups.

RESULTS

The mean number of patients per 100,000 children per year was 3.5 ± 1.2 in Group 1 and 3.6 ± 0.8 in Group 2. The clinical manifestations and laboratory findings at onset were comparable between Groups 1 and 2. Pathological findings in Group 1 and Group 2 were classified as ISKDC grade IIIa in 16 (26%) and 14 cases (24%), grade IIIb in 26 (43%) and 27 cases (46%), grade IV in 5 (8%) and 6 cases (10%)), grade V in 1 (2%) and 5 cases (8%), and grade VI in 2 (3%) and 2 cases (3%), respectively. There were no inter-group differences in ISKDC classification or rate of crescentic formation.

CONCLUSIONS

Our findings suggest that the incidence of HSPN and the severity of HSPN in patients between 1987 and 1997 were similar to those in patients between 1998 and 2008 and that the number of patients with severe HSPN has not decreased.

摘要

背景

最近,有一些关于日本儿童过敏性紫癜性肾炎(HSPN)发病率下降的报道。为了评估 HSPN 的发病率和严重程度,我们对福岛县 22 年来 HSPN 的流行病学和临床表现进行了研究。

方法

我们纳入了 1987 年至 1997 年间诊断为 HSPN 的 61 例患者(第 1 组)和 1998 年至 2008 年间诊断为 HSPN 的 59 例患者(第 2 组)。回顾性比较了两组之间的流行病学、临床特征、实验室数据、病理发现、治疗和结局。

结果

第 1 组和第 2 组每年每 10 万儿童的平均患者数分别为 3.5 ± 1.2 和 3.6 ± 0.8。第 1 组和第 2 组的发病时临床表现和实验室检查结果相似。第 1 组和第 2 组的病理发现分别为 ISKDC 分级 IIIa 型 16 例(26%)和 14 例(24%),IIIb 型 26 例(43%)和 27 例(46%),IV 型 5 例(8%)和 6 例(10%),V 型 1 例(2%)和 5 例(8%),VI 型 2 例(3%)和 2 例(3%)。两组间 ISKDC 分级或新月体形成率无差异。

结论

我们的研究结果表明,1987 年至 1997 年期间 HSPN 的发病率和严重程度与 1998 年至 2008 年期间相似,且严重 HSPN 的患者数量并未减少。

相似文献

1
The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan.日本福岛县 22 年间过敏性紫癜肾炎的发病及严重程度。
Int Urol Nephrol. 2010 Dec;42(4):1023-9. doi: 10.1007/s11255-009-9701-3. Epub 2010 Jan 10.
2
[Relationship between clinical manifestations and renal pathology in children with Henoch-Schonlein purpura nephritis].[过敏性紫癜性肾炎患儿临床表现与肾脏病理的关系]
Zhongguo Dang Dai Er Ke Za Zhi. 2007 Apr;9(2):129-32.
3
Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.儿童过敏性紫癜肾炎 3a 级或 3b 级的临床转归。
Pediatr Nephrol. 2011 Jul;26(7):1083-8. doi: 10.1007/s00467-011-1834-9. Epub 2011 Mar 9.
4
[Henoch-Schönlein purpura nephritis (HSPN) in children: comparison of the incidence and severity between two 12-year groups].儿童过敏性紫癜性肾炎(HSPN):两个12年组间发病率与严重程度的比较
Nihon Jinzo Gakkai Shi. 2000 Jan;42(1):36-40.
5
Clinical manifestations of Henoch-Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR).过敏性紫癜性肾炎和IgA肾病的临床表现:来自日本肾活检登记处(J-RBR)数据的比较分析
Clin Exp Nephrol. 2016 Aug;20(4):552-560. doi: 10.1007/s10157-015-1177-0. Epub 2015 Oct 11.
6
[Treatment of Henoch-Schönlein purpura nephritis in children with tonsillectomy].[扁桃体切除术治疗儿童过敏性紫癜性肾炎]
Nihon Jibiinkoka Gakkai Kaiho. 2006 Sep;109(9):696-702. doi: 10.3950/jibiinkoka.109.696.
7
Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.紫癜性肾炎患儿肾组织中足细胞标记蛋白的表达及其与尿足细胞数量的相关性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Feb;37(2):161-7. doi: 10.3969/j.issn.1672-7347.2012.02.009.
8
Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.与儿童过敏性紫癜性肾炎肾新月体形成相关的危险因素:一项回顾性队列研究。
BMC Pediatr. 2020 Nov 2;20(1):501. doi: 10.1186/s12887-020-02404-2.
9
Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis.儿童过敏性紫癜肾炎中毛细血管内增生与肾病范围蛋白尿的相关性。
Pediatr Nephrol. 2019 Apr;34(4):663-670. doi: 10.1007/s00467-018-4134-9. Epub 2018 Nov 10.
10
[Expression of vascular endothelial growth factor is related to microvessel injury of renal interstitium in children with Henoch Schönlein purpura nephritis].[血管内皮生长因子表达与过敏性紫癜性肾炎患儿肾间质微血管损伤的关系]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Sep;11(9):717-21.

引用本文的文献

1
National recommendations for the management of children and young people with IgA vasculitis: a best available evidence, group agreement-based approach.儿童和青少年IgA血管炎管理的国家建议:基于现有最佳证据和专家共识的方法
Arch Dis Child. 2024 Dec 13;110(1):67-76. doi: 10.1136/archdischild-2024-327364.
2
Urinary complement proteins are increased in children with IgA vasculitis (Henoch-Schönlein purpura) nephritis.尿补体蛋白在 IgA 血管炎(过敏性紫癜肾炎)患儿中增加。
Pediatr Nephrol. 2023 May;38(5):1491-1498. doi: 10.1007/s00467-022-05747-3. Epub 2022 Oct 13.
3
Epidemiology of biopsy-proven Henoch-Schönlein purpura nephritis in children: A nationwide survey in Japan.

本文引用的文献

1
Henoch-Schönlein nephritis: a nationwide study.过敏性紫癜肾炎:一项全国性研究。
Nephron Clin Pract. 2009;112(3):c199-204. doi: 10.1159/000218109. Epub 2009 May 13.
2
Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.儿童过敏性紫癜性肾炎基于治疗的文献。
Pediatr Nephrol. 2009 Oct;24(10):1901-11. doi: 10.1007/s00467-008-1066-9. Epub 2008 Dec 9.
3
Henoch-Schönlein purpura: a long-term prospective study in Greek children.过敏性紫癜:希腊儿童的一项长期前瞻性研究。
日本全国性调查:经活检证实的儿童过敏性紫癜肾炎的流行病学。
PLoS One. 2022 Jul 8;17(7):e0270796. doi: 10.1371/journal.pone.0270796. eCollection 2022.
4
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
5
Association between Tfh and PGA in children with Henoch-Schönlein purpura.过敏性紫癜患儿中滤泡辅助性T细胞与紫癜性肾炎的关系。
Open Med (Wars). 2021 Jul 2;16(1):986-991. doi: 10.1515/med-2021-0318. eCollection 2021.
6
IgA vasculitis.IgA 血管炎。
Semin Immunopathol. 2021 Oct;43(5):729-738. doi: 10.1007/s00281-021-00874-9. Epub 2021 Jun 25.
7
Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.低剂量皮质类固醇联合吗替麦考酚酯可能是老年起病的 ISKDC 分级 VI 型 IgA 血管炎的有效治疗方法。
CEN Case Rep. 2021 Feb;10(1):46-52. doi: 10.1007/s13730-020-00513-6. Epub 2020 Aug 4.
8
Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps.儿童IgA血管炎(过敏性紫癜)——进展与知识空白
Front Pediatr. 2019 Jun 27;7:257. doi: 10.3389/fped.2019.00257. eCollection 2019.
9
Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea.三十年来过敏性紫癜临床特征的变化:韩国单家医院的观察性研究。
Clin Rheumatol. 2019 Oct;38(10):2811-2818. doi: 10.1007/s10067-019-04628-9. Epub 2019 Jun 8.
10
The incidence and severity of IgA vasculitis with nephritis over a 10-year period in our hospital.我院10年间IgA肾病相关性血管炎的发病率及严重程度。
Fukushima J Med Sci. 2017 Dec 19;63(3):135-140. doi: 10.5387/fms.2017-14. Epub 2017 Sep 14.
J Clin Rheumatol. 2008 Dec;14(6):324-31. doi: 10.1097/RHU.0b013e31817a240a.
4
Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature.儿童过敏性紫癜:5年期间150例病例的流行病学及临床分析并文献复习
Semin Arthritis Rheum. 2005 Dec;35(3):143-53. doi: 10.1016/j.semarthrit.2005.08.007.
5
Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study.甲泼尼龙和尿激酶冲击疗法联合或不联合环磷酰胺治疗重症过敏性紫癜性肾炎的疗效:一项临床和组织病理学研究
Nephrol Dial Transplant. 2004 Apr;19(4):858-64. doi: 10.1093/ndt/gfg617.
6
Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis.甲泼尼龙和尿激酶冲击疗法治疗重症过敏性紫癜性肾炎的疗效
Pediatrics. 2003 Apr;111(4 Pt 1):785-9. doi: 10.1542/peds.111.4.785.
7
Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins.不同种族儿童中过敏性紫癜、川崎病及罕见血管炎的发病率。
Lancet. 2002 Oct 19;360(9341):1197-202. doi: 10.1016/S0140-6736(02)11279-7.
8
[Henoch-Schönlein purpura nephritis (HSPN) in children: comparison of the incidence and severity between two 12-year groups].儿童过敏性紫癜性肾炎(HSPN):两个12年组间发病率与严重程度的比较
Nihon Jinzo Gakkai Shi. 2000 Jan;42(1):36-40.
9
Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children.血浆置换作为儿童快速进展性过敏性紫癜性肾炎的单一治疗方法。
Am J Kidney Dis. 1999 Mar;33(3):427-33. doi: 10.1016/s0272-6386(99)70178-2.
10
Multiple combined therapy for severe Henoch-Schönlein nephritis in children.儿童重症过敏性紫癜性肾炎的多种联合治疗
Pediatr Nephrol. 1998 Apr;12(3):244-8. doi: 10.1007/s004670050447.